Activity of eltrombopag in severe aplastic anemia

Since the approval of horse antithymocyte globulin (ATG) decades ago, there was a long hiatus in therapies with activity in severe aplastic anemia (SAA). This scenario changed in 2014 when eltrombopag, a thrombopoietin receptor agonist, was approved for SAA after an insufficient response to initial...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hematology Am Soc Hematol Educ Program
Yazar: Scheinberg, Phillip
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2018
Konular:
Severe Aplastic Anemia: Diagnosis and Management in an Era of Effective Therapies
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6245975/
https://ncbi.nlm.nih.gov/pubmed/30504345
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller